Lori M. Henderson insider trades: Moderna (MRNA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lori reports to the SEC
Open-market buys and sales
47 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 27, 2021 | MRNA | ↓ Sell | 6,600 | $174.20 | $1.1M | Direct | May 28, 2021 (1d) |
| May 25, 2021 | MRNA | ↓ Sell | 6,600 | $166.58 | $1.1M | Direct | May 27, 2021 (2d) |
| May 20, 2021 | MRNA | ↓ Sell | 6,600 | $159.92 | $1.1M | Direct | May 21, 2021 (1d) |
| May 18, 2021 | MRNA | ↓ Sell | 6,600 | $160.16 | $1.1M | Direct | May 20, 2021 (2d) |
| May 13, 2021 | MRNA | ↓ Sell | 6,600 | $152.60 | $1.0M | Direct | May 14, 2021 (1d) |
| May 11, 2021 | MRNA | ↓ Sell | 6,600 | $151.31 | $999K | Direct | May 13, 2021 (2d) |
| May 6, 2021 | MRNA | ↓ Sell | 6,600 | $147.82 | $976K | Direct | May 7, 2021 (1d) |
| May 4, 2021 | MRNA | ↓ Sell | 6,600 | $185.25 | $1.2M | Direct | May 6, 2021 (2d) |
| Apr 29, 2021 | MRNA | ↓ Sell | 6,600 | $182.49 | $1.2M | Direct | Apr 30, 2021 (1d) |
| Apr 27, 2021 | MRNA | ↓ Sell | 6,600 | $178.29 | $1.2M | Direct | Apr 29, 2021 (2d) |
| Apr 22, 2021 | MRNA | ↓ Sell | 6,600 | $168.26 | $1.1M | Direct | Apr 23, 2021 (1d) |
| Apr 20, 2021 | MRNA | ↓ Sell | 6,600 | $160.32 | $1.1M | Direct | Apr 22, 2021 (2d) |
| Apr 15, 2021 | MRNA | ↓ Sell | 6,600 | $158.76 | $1.0M | Direct | Apr 16, 2021 (1d) |
| Apr 13, 2021 | MRNA | ↓ Sell | 6,600 | $146.62 | $968K | Direct | Apr 14, 2021 (1d) |
| Apr 8, 2021 | MRNA | ↓ Sell | 6,600 | $132.85 | $877K | Direct | Apr 9, 2021 (1d) |
| Apr 6, 2021 | MRNA | ↓ Sell | 6,600 | $130.01 | $858K | Direct | Apr 8, 2021 (2d) |
| Apr 1, 2021 | MRNA | ↓ Sell | 6,600 | $132.51 | $875K | Direct | Apr 2, 2021 (1d) |
| Mar 30, 2021 | MRNA | ↓ Sell | 6,600 | $123.30 | $814K | Direct | Apr 1, 2021 (2d) |
| Mar 25, 2021 | MRNA | ↓ Sell | 6,600 | $126.88 | $837K | Direct | Mar 26, 2021 (1d) |
| Mar 23, 2021 | MRNA | ↓ Sell | 6,600 | $145.55 | $961K | Direct | Mar 25, 2021 (2d) |
| Mar 18, 2021 | MRNA | ↓ Sell | 6,600 | $144.39 | $953K | Direct | Mar 19, 2021 (1d) |
| Mar 16, 2021 | MRNA | ↓ Sell | 6,600 | $148.50 | $980K | Direct | Mar 18, 2021 (2d) |
| Mar 11, 2021 | MRNA | ↓ Sell | 6,600 | $133.29 | $880K | Direct | Mar 12, 2021 (1d) |
| Mar 9, 2021 | MRNA | ↓ Sell | 6,600 | $127.11 | $839K | Direct | Mar 10, 2021 (1d) |
| Mar 4, 2021 | MRNA | ↓ Sell | 6,600 | $128.58 | $849K | Direct | Mar 5, 2021 (1d) |
| Mar 2, 2021 | MRNA | ↓ Sell | 6,600 | $153.77 | $1.0M | Direct | Mar 4, 2021 (2d) |
| Oct 21, 2020 | MRNA | ↓ Sell | 32,000 | $70.16 | $2.2M | Direct | Oct 23, 2020 (2d) |
| Jun 18, 2020 | MRNA | ↓ Sell | 64,000 | $63.03 | $4.0M | Direct | Jun 19, 2020 (1d) |
| May 20, 2020 | MRNA | ↓ Sell | 64,000 | $70.00 | $4.5M | Direct | May 22, 2020 (2d) |
| Nov 16, 2016 | AMRI | ↓ Sell | 6,000 | $17.00 | $102K | Direct | Nov 17, 2016 (1d) |
| Oct 1, 2014 | AMRI | ↓ Sell | 1,000 | $21.48 | $21K | Direct | Oct 1, 2014 (0d) |
| Sep 2, 2014 | AMRI | ↓ Sell | 2,500 | $19.56 | $49K | Direct | Sep 3, 2014 (1d) |
| Aug 12, 2014 | AMRI | ↓ Sell | 30,000 | $19.05 | $572K | Direct | Aug 13, 2014 (1d) |
| Aug 1, 2014 | AMRI | ↓ Sell | 2,500 | $18.56 | $46K | Direct | Aug 1, 2014 (0d) |
| Jul 1, 2014 | AMRI | ↓ Sell | 2,500 | $20.62 | $52K | Direct | Jul 2, 2014 (1d) |
| Jun 2, 2014 | AMRI | ↓ Sell | 2,500 | $16.32 | $41K | Direct | Jun 4, 2014 (2d) |
| May 1, 2014 | AMRI | ↓ Sell | 2,500 | $15.73 | $39K | Direct | May 1, 2014 (0d) |
| Apr 1, 2014 | AMRI | ↓ Sell | 2,500 | $18.74 | $47K | Direct | Apr 2, 2014 (1d) |
| Dec 7, 2011 | AMRI | ↑ Buy | 5,900 | $2.47 | $15K | Direct | Dec 7, 2011 (0d) |
| Jan 30, 2008 | MFLO | ↓ Sell10b5-1 | 1,667 | $13.25 | $22K | Direct | Feb 1, 2008 (2d) |
| Dec 11, 2007 | MFLO | ↓ Sell | 10,163 | $16.40 | $167K | Direct | Dec 13, 2007 (2d) |
| May 17, 2007 | MFLO | ↓ Sell10b5-1 | 2,565 | $18.80 | $48K | Direct | May 18, 2007 (1d) |
| Feb 16, 2007 | MFLO | ↓ Sell10b5-1 | 3,002 | $14.23 | $43K | Direct | Feb 20, 2007 (4d) |
| Jan 17, 2007 | MFLO | ↓ Sell10b5-1 | 4,000 | $14.03 | $56K | Direct | Jan 18, 2007 (1d) |
| Jan 3, 2007 | MFLO | ↓ Sell10b5-1 | 600 | $13.94 | $8K | Direct | Jan 4, 2007 (1d) |
| Jan 3, 2007 | MFLO | ↓ Sell10b5-1 | 233 | $13.70 | $3K | Direct | Jan 4, 2007 (1d) |
| Sep 15, 2006 | MFLO | ↓ Sell | 1,000 | $11.66 | $12K | Direct | Sep 15, 2006 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MRNA insiders
Open-market trades in the last 12 months
About Lori M. Henderson's insider trades
Lori M. Henderson is General Counsel and Secretary at Moderna (MRNA). Since Sep 15, 2006, Lori has reported 1 open-market purchase worth $15K and 46 sales worth $38.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
6 sales (0% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (37 filings), shares withheld for taxes (25 filings), grants and awards (14 filings), shares returned to the company (9 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.